| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/08/2002 | WO2002000885A3 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 08/08/2002 | WO2002000840A3 Human lyases |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 08/08/2002 | WO2001092547A3 Modified bovine adenovirus having altered tropism |
| 08/08/2002 | WO2001092306A3 Therapeutic compounds for ovarian cancer |
| 08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
| 08/08/2002 | WO2001088101A3 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT |
| 08/08/2002 | WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 08/08/2002 | WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001075435A3 Fluorescence assay for gamma-secretase activity and inhibitors |
| 08/08/2002 | WO2001075171A3 Methods, compositions and kits for the detection and monitoring of breast cancer |
| 08/08/2002 | WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 08/08/2002 | WO2001059152A9 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/08/2002 | WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 08/08/2002 | WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use |
| 08/08/2002 | WO2001013714A3 Prostatic cell line and animal model of a prostatic tumor |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | US20020108151 Regulation of quinolate phosphoribosyl transferase expression |
| 08/08/2002 | US20020108148 Nucleic acid sequences to proteins involved in isoprenoid synthesis |
| 08/08/2002 | US20020108143 Theobromine synthase polypeptide of coffee plant and the gene encoding said polypeptide |
| 08/08/2002 | US20020108142 Application of bi-directional promoters for modification of gene expression |
| 08/08/2002 | US20020108139 Production of a plant resistant to low temperatures |
| 08/08/2002 | US20020108137 Nucleotide sequences coding preferential polypeptide for use in gene and tumor therapy |
| 08/08/2002 | US20020107869 Novel implant and novel vector for the treatment of acquired diseases |
| 08/08/2002 | US20020107385 Human breast tumor-specific proteins |
| 08/08/2002 | US20020107383 Guanosine diphosphate activation protein; for use in the of genetic disorders and cancer |
| 08/08/2002 | US20020107372 Nucleotide sequences coding membrane protein for use in the treatment of inflammation,lung defects and viral diseases |
| 08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
| 08/08/2002 | US20020107368 Helicobacter proteins, gene sequences and uses thereof |
| 08/08/2002 | US20020107365 Ligands for flt3 receptors |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107362 Novel fluorescent proteins |
| 08/08/2002 | US20020107361 Novel metalloproteases having thrombospondin domains and nucleic acid compositions encoding the same |
| 08/08/2002 | US20020107225 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 08/08/2002 | US20020107214 Using chimeric restriction endonucleases; treating or prophylaxis of a genetic disease |
| 08/08/2002 | US20020107213 Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein E |
| 08/08/2002 | US20020107205 Exposing to a matrix of type I collagen and bone morphogenic protein-4 (BMP-4) |
| 08/08/2002 | US20020107194 Able to bind to a Notch protein forming Delta-Notch complex |
| 08/08/2002 | US20020107180 Cell surface glycoproteins |
| 08/08/2002 | US20020106799 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 08/08/2002 | US20020106795 Pluripotent stem cell; for use in the treatment of thalassemia and sickle cell anemia |
| 08/08/2002 | US20020106794 Purifying dopamine cells; obtain cells, transfect with vector coding fluorescent molecules, detect fluorescent cells, recover fluorscent cells |
| 08/08/2002 | US20020106793 Tissue engineering scaffolds promoting matrix protein production |
| 08/08/2002 | US20020106792 Immunoisolation of preferential cells; obtain cells, incubate with n-acetylglucosamine, encapsulate, recover cells |
| 08/08/2002 | US20020106791 Nutrient broth containin mitogen for use in cell propagation and wound healing |
| 08/08/2002 | US20020106790 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells |
| 08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 08/08/2002 | US20020106778 Human PTTG polypeptide and method for producing it |
| 08/08/2002 | US20020106769 UDP-D-glucose: limonoid glucosyltransferase |
| 08/08/2002 | US20020106768 Pesticidal protein for use in biological pest controlth Cry6A toxin |
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof |
| 08/08/2002 | US20020106742 Nucleic acids encoding active and inactive CCR5 chemokine receptors |
| 08/08/2002 | US20020106735 Novel Bcl-2 related proline rich protein (BPR) |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106729 Nucleotide sequences for use as tools in genetic engineering |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106724 RNA-binding protein |
| 08/08/2002 | US20020106723 Receptor for latrotoxin from insects |
| 08/08/2002 | US20020106720 Cre-inducible expression system |
| 08/08/2002 | US20020106703 Screening cell pool for pancreatic progenitor cells; obtain mammalian cell culture, incubate with marker protein, detect those cells bound by marker protein |
| 08/08/2002 | US20020106694 Use of computer to designing preferential polypeptides; obtain computer, input polypeptide sequence data, adjust polypeptide sequence data, analyse potential activities associated with adjustment |
| 08/08/2002 | US20020106685 Method for specifically detecting tumor cells and their precursors in uterine cervical smears by simultaneously measuring at least 2 different molecular markers |
| 08/08/2002 | US20020106680 Joining preferential nucleotide sequences; generate solid phase, incubate with nucleotide sequences, remove nucleotide sequence which have protrusions from terminals, recover bound nucleotide sequences |
| 08/08/2002 | US20020106671 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106642 Protease for use in the treatment and prevention of viral disease and infections |
| 08/08/2002 | US20020106641 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 08/08/2002 | US20020106639 Postweaning multisystemic wasting syndrome virus from pigs |
| 08/08/2002 | US20020106636 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 08/08/2002 | US20020106633 Vitro assay for testing gabapentinoid activity |
| 08/08/2002 | US20020106631 Recombinant, active caspases and uses thereof |
| 08/08/2002 | US20020106629 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin |
| 08/08/2002 | US20020106628 Methods of modifying eukaryotic cells |
| 08/08/2002 | US20020106378 Materials and methods for intracellular transport and their uses |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106360 Administering a modulator of nitric oxide levels to oocyte for modulating oocyte activation |
| 08/08/2002 | US20020106354 Cellular and animal models for diseases associated with altered mitochondrial function |
| 08/08/2002 | US20020106353 Donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over recipient graft site |
| 08/08/2002 | US20020106352 Introducing cartilage producing cells into the skin contour irregularity thereby effecting cosmetic repair thereof |
| 08/08/2002 | DE10104952A1 Vektorsystem zum Screening von Wirkstoffen Vector system for screening active substances |
| 08/08/2002 | CA2437342A1 Method for producing recombinant trypsin |
| 08/08/2002 | CA2437121A1 Juvenile hormone esterase |
| 08/08/2002 | CA2437072A1 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
| 08/08/2002 | CA2437016A1 Screening method for infection agent of prion disease |
| 08/08/2002 | CA2436661A1 Novel nucleic acid and polypeptide molecules |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2435709A1 Hair follicle neogenesis by injection of follicle progenitor cells |
| 08/08/2002 | CA2434968A1 Method for the evolutionary design of biochemical reaction networks |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |